Key result
Percutaneous PFO closure rapidly improves oxygenation in platypnea-orthodeoxia syndrome identified via sitting-position echocardiography.
Why the study?
Does percutaneous PFO closure resolve hypoxemia in a patient with Platypnea-Orthodeoxia Syndrome?
Case Report (n=1)
Does percutaneous PFO closure resolve hypoxemia in a patient with Platypnea-Orthodeoxia Syndrome?
This case highlights the utility of sitting-position transesophageal echocardiography for diagnosing posture-dependent shunting in Platypnea-Orthodeoxia Syndrome and demonstrates the effectiveness of percutaneous PFO closure as a definitive therapy.
Supports PFO closure for platypnea-orthodeoxia syndrome; extends evidence for definitive percutaneous therapy in select patients.
BACKGROUND: Platypnea-orthodeoxia syndrome (POS) is characterized by dyspnea and hypoxemia that worsen in the upright position and improve when supine. Both an anatomical intracardiac defect and functional factors that cause posture-dependent right-to-left shunting are required for manifestation. CASE SUMMARY: A 74-year-old woman with hypertension and dyslipidemia presented with progressive dyspnea and hypoxemia without evidence of pulmonary disease. Her oxygen saturation was 80% to 83% in the upright position versus 95% to 99% in the supine position, suggesting POS. Transesophageal echocardiography revealed a patent foramen ovale (PFO) with posture-dependent shunting and an atrial septal aneurysm. Computed tomography revealed aortic elongation compressing the right atrium. She underwent percutaneous PFO closure using a Gore Cardioform septal occluder, resulting in complete resolution of hypoxemia. DISCUSSION: This case highlights the importance of positional assessment and the utility of sitting-position echocardiography to detect posture-dependent right-to-left shunting that may be missed on conventional supine imaging. TAKE-HOME MESSAGE: Sitting-position transesophageal echocardiography is a useful diagnostic method for identifying posture-dependent shunting in POS, and percutaneous PFO closure provides definitive therapy with rapid improvement in oxygenation.
No takes yet. Share an insight, caveat, or question.
Kakura et al. (2026) conducted a case report in Platypnea-orthodeoxia syndrome (n=1). Percutaneous PFO closure was evaluated on Resolution of hypoxemia. Percutaneous PFO closure resulted in complete resolution of hypoxemia (upright oxygen saturation improved from 80-83%) in a 74-year-old woman with platypnea-orthodeoxia syndrome.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: